InvestorsHub Logo
icon url

cowtown jay

03/13/21 5:51 PM

#26125 RE: DonDonDonDon #26124

Well, we have some agreement in terms of the market makers gapping our spread, that's good.

And as far as keeping HGEN shares prices in the neighborhood of CYDY's, the market makers may be executing trades at the prices a Big Pharma or SPAC want to enter the market, paying the least amount for our shares as possible.

Never closer to FDA approval, and trading at substantially lower prices?
icon url

Scooter McCabe

03/13/21 7:02 PM

#26126 RE: DonDonDonDon #26124

Or they could be betting against monoclonal antibodies since none of them have turned staggering results. There is a decent chance HGEN just trends positive on mortality as well and has to refine their study. Again.

April 1st puts might not be a bad idea.